Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Dermatologic assessment from a distance: the use of teledermatology in an outpatient chemotherapy infusion center.

Gordon J.

Clin J Oncol Nurs. 2012 Aug;16(4):418-20. doi: 10.1188/12.CJON.418-420. Review.

PMID:
22842694
2.

Telemedicine in dermatology: a randomised controlled trial.

Bowns IR, Collins K, Walters SJ, McDonagh AJ.

Health Technol Assess. 2006 Nov;10(43):iii-iv, ix-xi, 1-39.

3.
4.

Telemedicine for dermatology care in rural patients.

Burgiss SG, Julius CE, Watson HW, Haynes BK, Buonocore E, Smith GT.

Telemed J. 1997 Fall;3(3):227-33.

PMID:
10174347
5.

Administrative and technical support of ambulatory infusional cancer chemotherapy (ICC).

Moore C, Strong D.

J Infus Chemother. 1996 Fall;6(4):161-3. Review.

PMID:
9229310
6.

Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.

Borovicka JH, Calahan C, Gandhi M, Abraham TS, Kwasny MJ, Haley AC, West DP, Lacouture ME.

Arch Dermatol. 2011 Dec;147(12):1403-9. doi: 10.1001/archdermatol.2011.719.

PMID:
22184762
7.

Ambulatory infusional cancer chemotherapy: nursing role in patient management. The Cancer Center of Boston.

Moore C, Strong D, Childress J, Fougere B, Gotthardt S.

J Infus Chemother. 1996 Fall;6(4):164-70. Review.

PMID:
9229311
8.

Chemotherapy and cutaneous toxicities: implications for oncology nurses.

Viale PH.

Semin Oncol Nurs. 2006 Aug;22(3):144-51. Review.

PMID:
16893743
9.

Teledermatological monitoring of leg ulcers in cooperation with home care nurses.

Binder B, Hofmann-Wellenhof R, Salmhofer W, Okcu A, Kerl H, Soyer HP.

Arch Dermatol. 2007 Dec;143(12):1511-4.

PMID:
18086999
10.
11.

What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.

Esper P, Gale D, Muehlbauer P.

Clin J Oncol Nurs. 2007 Oct;11(5):659-66. Review.

PMID:
17962174
12.

An innovative off-campus infusion suite designed to improve experiences of patients with cancer.

Gordon J, Gruber M.

Clin J Oncol Nurs. 2012 Aug;16(4):354-9. doi: 10.1188/12.CJON.354-359. Review.

PMID:
22842686
13.

Relationship between social support and fatigue in geriatric patients receiving outpatient chemotherapy.

KarakoƧ T, Yurtsever S.

Eur J Oncol Nurs. 2010 Feb;14(1):61-7. doi: 10.1016/j.ejon.2009.07.001. Epub 2009 Sep 4.

PMID:
19733118
14.

[The development of an outpatient treatment system for cancer chemotherapy].

Igarashi T.

Gan To Kagaku Ryoho. 2000 Oct;27(11):1647-55. Review. Japanese.

PMID:
11057314
15.

Patient satisfaction with teledermatology is related to perceived quality of life.

Williams TL, Esmail A, May CR, Griffiths CE, Shaw NT, Fitzgerald D, Stewart E, Mould M, Morgan M, Pickup L, Kelly S.

Br J Dermatol. 2001 Dec;145(6):911-7.

PMID:
11899144
16.

Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors.

Boucher J, Olson L, Piperdi B.

Clin J Oncol Nurs. 2011 Oct;15(5):501-8. doi: 10.1188/11.CJON.501-508.

PMID:
21951736
17.

A randomized controlled trial to assess the clinical effectiveness of both realtime and store-and-forward teledermatology compared with conventional care.

Loane MA, Bloomer SE, Corbett R, Eedy DJ, Hicks N, Lotery HE, Mathews C, Paisley J, Steele K, Wootton R.

J Telemed Telecare. 2000;6 Suppl 1:S1-3.

PMID:
10793956
18.

Pediatric teledermatology--a survey of current use.

Fieleke DR, Edison K, Dyer JA.

Pediatr Dermatol. 2008 Mar-Apr;25(2):158-62. doi: 10.1111/j.1525-1470.2008.00624.x.

PMID:
18429770
19.

Application of ambulatory infusion devices in infusional cancer chemotherapy: a model for nursing management.

Moore C, Herbst S, Lawson M.

J Infus Chemother. 1996 Fall;6(4):181-5. Review.

PMID:
9229313
20.

Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.

Nanninga AG, de Vries EG, Willemse PH, Oosterhuis BE, Sleijfer DT, Hoekstra HJ, Mulder NH.

Eur J Cancer. 1991;27(2):147-9.

PMID:
1827278

Supplemental Content

Support Center